跳至主要内容
临床试验/CTRI/2026/04/109429
CTRI/2026/04/109429尚未招募不适用

A Randomised Controlled Study to Determine the Appropriate Time for Placement of LMA R SupremeTM Supraglottic Airway Device with Propofol Induction.

Tata Memorial Hospital1 个研究点 分布在 1 个国家目标入组 320 人开始时间: 2026年5月11日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
320
试验地点
1

研究概览

简要总结

LMA® SupremeTM supraglottic airway device is a device inserted through the mouth and is used to deliver oxygen to patients under general anaesthesia Before inserting the LMA patients are usually administered a medicine called Propofol to make them unconscious However there is no clarity regarding the best time of LMA insertion after the administration of Propofol  Also it is not very clear whether the time interval between when a person becomes unconscious to when the LMA is inserted affects the ease of placement of LMA If it is placed too early or too late after administering Propofol it can cause problems like gagging coughing or difficulty in placing the device

This study looks at the best time to easily insert LMA® SupremeTM type of supraglottic airway device after administering Propofol Finding the best time for placement can make surgeries safer and more comfortable for patients

People undergoing surgery which will need placement of LMA® SupremeTM type of supraglottic airway device will be randomly assigned to three different groups Each group will have the LMA inserted at a specific time after receiving Propofol The doctors will then observe and make a note of the parameters used to assess the ease of LMA insertion

The results will help doctors to understand the best time to insert the supraglottic airway device after giving Propofol This will help to improve safety reduce complications and make anaesthesia smoother for patients

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Adult patients more than or equal to18 years of age with an American Society of Anaesthesiologists ASA I.
  • III scheduled for elective surgeries under general anaesthesia for which LMA is an appropriate choice for airway management.

排除标准

  • Patient refusal to participate
  • Patient at risk of aspiration like patients who are inadequately fasting, patients with intestinal obstruction/perforation.
  • Patients undergoing emergency surgery
  • Patients with upper airway obstructions such as airway tumor, abscess, edema and/or hematoma
  • Patient with disrupted upper airway, facial or upper airway trauma, airway burns
  • Patients who are morbidly obese(BMI more than 40kg/m²)
  • Pregnant patients
  • Patients with poor lung compliance
  • Patients in whom iv Propofol is to be avoided.

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Bhakti Trivedi

ACTREC

研究点 (1)

Loading locations...

相似试验